These drugs are the latest in a growing list of oncology medications in short supply:
Azacitidine injections: Three drugmakers stopped making 100 milligram solutions of the leukemia drug.
Iobenguane I-131 injections: Progenics Pharmaceuticals stopped making two solutions because of low demand for the oncology medication.
At the Becker's Perioperative Summit, taking place October 29–31 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
